Answers are grounded in this paper and cite their sources.
Background: Thalassemia is one of the most common autosomal recessive disorders worldwide. It is a genetic disorder of hemoglobin synthesis. Beta-thalassemia has a particularly high prevalence in populations in the Mediterranean, Middle East, and India. Long-term blood transfusion, splenectomy, and iron chelation therapy- these interventions play a crucial role in the management of thalassemia patients. Objective: This is a demographic study aimed to determine the age and sex distribution, clinic-laboratory profile, investigation, complications to management of transfusion-dependent B-thalassemia major in children at El-Helal hospital in Sohag city. Patients and Method: This study was carried out prospectively from 1st April 2019 to the 31st December 2021, the study included total of 166 children aged between 6 months to 12 years, clinically diagnosed with transfusion-dependent β-thalassemia major attending hematology clinic at Sohag El-Helal Hospital for Health Insurance. Studied children were subjected to complete history, clinical examination and laboratory evaluation. Results: A total of 166 children that age range from 6 months to 12 years, with a mean age of 9.2±4.4 years, most of them were male 122 (73.5%) and female 44 (26.5%). There was a significant statistical attachment between both sex and the Consanguinity, 151 (91%). Allergic reactions were developed in 12 (7.2 %) patients during blood transfusion. Splenomegaly was reported to be a major complication among study patients. Conclusion: Severe anemia is present in nearly all patients; Serum ferritin concentration accurately reflects high body iron stores. liver, kidney, bone, and endocrine functions significantly deteriorate in almost all studied patients.
No takes yet. Share an insight, caveat, or question.
A 2024 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: